NAT10-mediated N4-acetylcytidine modification is critical for YWHAH stabilization, highlighting the central role of epitranscriptomic regulation in modulating the tumor microenvironment and immune escape, and identifying YWHAH as a potential immunotherapeutic target in CRC (70). This evidence concerns the gene YWHAH and colorectal carcinoma.